Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical and Experimental Rheumatology|May 2, 2012
Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI)Milka Maravic, Baptiste Jouaneton, Alexandre Vainchtock, et al.Clinics and Research in Hepatology and Gastroenterology|January 1, 2013
How did chronic hepatitis C impact costs related to hospital health care in France in 2009?Michel Rotily, Alexandre Vainchtock, Baptiste Jouaneton, et al.IEEE Journal of Biomedical and Health Informatics|September 4, 2020
Automatic and Explainable Labeling of Medical Event Logs With AutoencodingHugo De Oliveira, Vincent Augusto, Baptiste Jouaneton, et al.Plos One|January 11, 2019
Hospital costs impact of post ischemic stroke dysphagia: Database analyses of hospital discharges in France and SwitzerlandNatalia Muehlemann, Baptiste Jouaneton, Lucie de Léotoing, et al.Journal of Medical Economics|May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in FranceValentine Grumberg, Christos Chouaïd, François-Emery Cotté, et al.Respiratory Medicine and Research|October 28, 2023
Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysisJean-Baptiste Assié, Valentine Grumberg, Dorothée Reynaud, et al.Therapeutic Advances in Medical Oncology|January 6, 2021
Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)Jean-Baptiste Assié, Romain Corre, Matteo Giaj Levra, et al.Therapeutic Advances in Medical Oncology|February 6, 2023
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world settingJean-Baptiste Assié, Christos Chouaïd, Hilario Nunes, et al.Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysisMatteo Giaj Levra, François-Emery Cotté, Romain Corre, et al.Pageof 1